> If this study was only conducted on patients who were already hospitalized I don't think it is a cohort that represents Remdesivir's intended users.
That's the scope of the authorized investigatory use in the US, so unless you think the Trump Administration is simultaneously promoting and sabotaging it, I think it's the intended target:
“VEKLURY® (remdesivir) is authorized for use under an EUA only for the treatment of adult and pediatric patients hospitalized with suspected or laboratory-confirmed COVID-19, and for whom use of an intravenous (IV) agent is clinically appropriate. VEKLURY must be administered via IV infusion.”
That's the scope of the authorized investigatory use in the US, so unless you think the Trump Administration is simultaneously promoting and sabotaging it, I think it's the intended target:
“VEKLURY® (remdesivir) is authorized for use under an EUA only for the treatment of adult and pediatric patients hospitalized with suspected or laboratory-confirmed COVID-19, and for whom use of an intravenous (IV) agent is clinically appropriate. VEKLURY must be administered via IV infusion.”
https://www.remdesivir.com/us/?gclsrc=aw.ds&&gclid=CjwKCAjwi...